EMD-55789

Single-particle
3.54 Å
EMD-55789
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 07/10/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-55789

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of vaccine candidate AHSV-4 VP2 DI-mi3 nanoparticle

EMD-55789

Single-particle
3.54 Å
EMD-55789
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 07/10/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Thermotoga maritima, African horse sickness virus 4
Sample: SC003-mi3 nanoparticles conjugated with AHSV-4 VP2 DI-SpyTag antigen

Deposition Authors: Martinez-Castillo A , Aebischer A, Fu L , Breard E , Zientara S , Kortekaas J , Beer M , Abrescia NGA
Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design.
Martinez-Castillo A , Aebischer A, Toneatti P, Fu L , Vitour D, Sailleau C, Hoffmann B , Franzke K , Eschbaumer M, Weber S , Calvo Pinilla E, Ortego J , Gil-Carton D , Breard E , Zientara S , Kortekaas J , Beer M , Abrescia NG
(2026) Nat Commun , 17
PUBMED: 42401561
DOI: doi:10.1038/s41467-026-75067-9
ISSN: 2041-1723
Grant Support: